Cat. No. | Product name | CAS No. |
DCC3623 |
Net-c343
Novel fluorescent RXR antagonist |
|
DCC3624 |
N-ethylglycine
Lidocaine metabolite, showing antinociceptive effects, inhibiting GlyT1-mediated glycine uptake |
627-01-0 |
DCC3625 |
N-ethylmaleimide
Modulator of the T1007 site, resulting in rapid activation of this transporter and potentiating KCC2 activity |
128-53-0 |
DCC3626 |
Neu321
Ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth |
1426937-35-0 |
DCC3627 |
Neu-4854
Novel potent Trypanosoma brucei Inhibitor |
|
DCC3628 |
Neu617
Novel inhibitor of the growth of protozoan parasites, against T. brucei bloodstream proliferation |
1432450-82-2 |
DCC3629 |
Neu-730
Novel inhibitor of TbrPDEB1, showing modest inhibition of T. brucei proliferation |
1622300-88-2 |
DCC3630 |
Neurodazole
Novel neurogenic inducer for converting pluripotent P19 cells into electrophysiologically active neurons |
|
DCC3631 |
Neuroprotectant-7
Novel neuroprotectant for Alzheimers disease, showing significant neuroprotection and antioxidative properties, crossing the blood-brain barrier (BBB) |
1610504-84-1 |
DCC3632 |
Neurotensin(8-13)
The neurotensin active fragment, eliciting behavioral responses typical of clinically used antipsychotic drugs when administered directly to the brain |
60482-95-3 |
DCC3633 |
Nexturastat A-crbn-12d
Novel potent HDAC6 degrader with promising antiproliferation activity in multiple myeloma (MM) cells |
|
DCC3634 |
Nfat-133
Inhibitor of NFAT-mediated transcription, leading to the suppression of interleukin-2 expression and T cell proliferation, showing immunosuppressive, antidiabetic, and antitrypanosomal activities |
|
DCC3635 |
Nf-kappab Inhibitor-2
First-in-class inhibitor of NF-κB signaling pathway by preventing the maturation of a rate-limiting multiprotein complex necessary for IKK activation |
|
DCC3636 |
N-formyl-met-phe
Neutrophil Dysfunction Test Peptide |
22008-60-2 |
DCC3637 |
Nfu1827
Novel inhibitor of human cytomegalovirus (HCMV) infection |
|
DCC3638 |
Ngd 98-2
New generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist |
355836-54-3 |
DCC3639 |
Ngd-8243
Novel TRPV1 Antagonist |
573678-04-3 |
DCC3640 |
Ngd9002
New generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist |
666256-06-0 |
DCC3641 |
Ngp1-01
Brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels, acting as chemosensitizer and circumvent the resistance of the plasmodia parasite against chloroquine (CQ) by inhibiting the p-glycoprotein efflux pump and enabling th |
33226-57-2 |
DCC3642 |
Nh2-bodipy
Novel cell-permeant probe for the super-resolution imaging of the endoplasmic reticulum in live cells |
|
DCC3643 |
Nh2-nplh2
Novel luciferin analog, enabling both sensitive and highly resolved imaging in vivo |
1629640-37-4 |
DCC3644 |
Nh2-uamc1110
UAMC1110 Conjugate Linker |